Using a prediction model and electronic health records from before the pandemic, researchers estimated the burden that COVID-19 would have on patients with chronic kidney disease in the United Kingdom.“During the coronavirus (COVID-19) pandemic, CKD has been associated with poor prognosis. Despite clinical and public health importance, CKD research to date in all stages, multimorbidity or
Prevalence of clinically significant anxiety and depression among adults in the United States increased during the first year of the COVID-19 pandemic compared with prior years, according to a study published in JAMA Network Open. “Concerns about adverse mental health effects of COVID-19 have been raised since the beginning of the pandemic,” Ronald C. Kessler, PhD, of the department
Black patients were less likely to receive quality oncologic treatment for gastrointestinal tract cancers compared with white patients, according to a study published in JAMA Network Open.
Perceived social support may benefit survivors of acute respiratory failure and other critical illnesses, researchers reported in Annals of the American Thoracic Society.“Nationally representative cohort studies have shown that being able to identify a friend or relative who could help with personal care is protective against prolonged nursing home stays for adults [older than] 65, and
Treatment with azithromycin from the time of diagnosis of cystic fibrosis in infancy did not reduce the extent of structural lung disease at age 36 months, but did reduce airway inflammation and morbidity, according to the COMBAT CF trial.In addition, azithromycin treatment was safe and improved some clinical outcomes, researchers reported in The Lancet Respiratory Medicine.